Logo image of LOT

LOTUS TECHNOLOGY INC (LOT) Stock Fundamental Analysis

NASDAQ:LOT - Nasdaq - US54572F1012 - ADR - Currency: USD

2.18  0 (0%)

Fundamental Rating

1

Overall LOT gets a fundamental rating of 1 out of 10. We evaluated LOT against 37 industry peers in the Automobiles industry. LOT may be in some trouble as it scores bad on both profitability and health. LOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LOT had negative earnings in the past year.
LOT had a negative operating cash flow in the past year.
LOT Yearly Net Income VS EBIT VS OCF VS FCFLOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

LOT's Return On Assets of -25.95% is in line compared to the rest of the industry. LOT outperforms 40.54% of its industry peers.
Industry RankSector Rank
ROA -25.95%
ROE N/A
ROIC N/A
ROA(3y)-14.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LOT Yearly ROA, ROE, ROICLOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

LOT's Gross Margin of 18.61% is fine compared to the rest of the industry. LOT outperforms 78.38% of its industry peers.
LOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LOT Yearly Profit, Operating, Gross MarginsLOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

More info and screens

1

2. Health

2.1 Basic Checks

LOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOT has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, LOT has a worse debt to assets ratio.
LOT Yearly Shares OutstandingLOT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 200M 400M 600M 800M
LOT Yearly Total Debt VS Total AssetsLOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

LOT has an Altman-Z score of -2.17. This is a bad value and indicates that LOT is not financially healthy and even has some risk of bankruptcy.
LOT's Altman-Z score of -2.17 is in line compared to the rest of the industry. LOT outperforms 40.54% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.17
ROIC/WACCN/A
WACC11.81%
LOT Yearly LT Debt VS Equity VS FCFLOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 200M -200M -400M -600M -800M

2.3 Liquidity

LOT has a Current Ratio of 0.50. This is a bad value and indicates that LOT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.50, LOT is doing worse than 75.68% of the companies in the same industry.
LOT has a Quick Ratio of 0.50. This is a bad value and indicates that LOT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.35, LOT is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.35
LOT Yearly Current Assets VS Current LiabilitesLOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for LOT have decreased strongly by -30116.41% in the last year.
EPS 1Y (TTM)-30116.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8109.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, LOT will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.35% on average per year.
LOT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.17% yearly.
EPS Next Y-32.38%
EPS Next 2Y4.5%
EPS Next 3Y14.11%
EPS Next 5Y15.35%
Revenue Next Year41.67%
Revenue Next 2Y38.31%
Revenue Next 3Y53.21%
Revenue Next 5Y50.17%

3.3 Evolution

LOT Yearly Revenue VS EstimatesLOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 1B 2B 3B
LOT Yearly EPS VS EstimatesLOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LOT. In the last year negative earnings were reported.
Also next year LOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LOT Price Earnings VS Forward Price EarningsLOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LOT Per share dataLOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as LOT's earnings are expected to grow with 14.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.5%
EPS Next 3Y14.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOTUS TECHNOLOGY INC

NASDAQ:LOT (6/13/2025, 8:18:11 PM)

2.18

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-27 2025-05-27
Earnings (Next)08-26 2025-08-26
Inst Owners8.25%
Inst Owner Change-8.77%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.48B
Analysts45
Price Target3.06 (40.37%)
Short Float %0.42%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.69
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.81
BVpS-1.21
TBVpS-1.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.61%
FCFM N/A
ROA(3y)-14.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 388.88%
Cap/Sales 38.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.35
Altman-Z -2.17
F-Score3
WACC11.81%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30116.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8109.43%
EPS Next Y-32.38%
EPS Next 2Y4.5%
EPS Next 3Y14.11%
EPS Next 5Y15.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year41.67%
Revenue Next 2Y38.31%
Revenue Next 3Y53.21%
Revenue Next 5Y50.17%
EBIT growth 1Y-8544.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.58%
EBIT Next 3Y22.24%
EBIT Next 5Y20.29%
FCF growth 1Y-101704%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65481.7%
OCF growth 3YN/A
OCF growth 5YN/A